TITLE

GIP and Bariatric Surgery

AUTHOR(S)
Rao, Raghavendra S.; Kini, Subhash
PUB. DATE
February 2011
SOURCE
Obesity Surgery;Feb2011, Vol. 21 Issue 2, p244
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Bariatric surgery is the most effective modality of achieving weight loss as well as the most effective treatment for type 2 diabetes mellitus (T2DM). Glucose-dependent insulinotropic polypeptide (GIP) is an incretin and is implicated in the pathogenesis of obesity and T2DM. Its role in weight loss and resolution of T2DM after bariatric surgery is very controversial. We have made an attempt to review the physiology of GIP and its role in weight loss and resolution of T2DM after bariatric surgery. We searched PubMed and included all relevant original articles (both human and animal) in the review. Whereas most human studies have shown a decrease in GIP post-malabsorptive bariatric surgery, the role of GIP in bariatric surgery done in animal experiments remains inconclusive.
ACCESSION #
57318822

 

Related Articles

  • Diabetes improvement after bariatric surgery is dependent on weight loss. KAPLAN, LEE M.; SEELEY, RANDY J.; HARRIS, JASON L. // Bariatric Times;Apr2014, Vol. 11 Issue 4, pc14 

    The article discusses the role of bariatric surgery for the treatment of type 2 diabetes mellitus (T2DM). Topics discussed include the gastrointestinal weight loss surgical procedures for improvement of T2DM, mechanism of action of postoperative improvement in diabetes and the effects of...

  • FXR is a molecular target for the effects of vertical sleeve gastrectomy. Ryan, Karen K.; Tremaroli, Valentina; Clemmensen, Christoffer; Kovatcheva-Datchary, Petia; Myronovych, Andriy; Karns, Rebekah; Wilson-Pérez, Hilary E.; Sandoval, Darleen A.; Kohli, Rohit; Bäckhed, Fredrik; Seeley, Randy J. // Nature;5/8/2014, Vol. 509 Issue 7499, p183 

    Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms...

  • Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. Paula, Aureo; Stival, Alessandro; Halpern, Alfredo; DePaula, Carolina; Mari, Andrea; Muscelli, Elza; Vencio, Sergio; Ferrannini, Ele; De Paula, Aureo Ludovico; Stival, Alessandro R; DePaula, Carolina C L // Journal of Gastrointestinal Surgery;Aug2011, Vol. 15 Issue 8, p1344 

    Introduction: Bariatric surgery in morbidly obese type 2 diabetic (T2DM) patients is associated with high rates of diabetes remission. We investigated the mechanisms of the anti-diabetic effect of the laparoscopic ileal interposition with sleeve gastrectomy (LII-SG) in normal weight...

  • Intensified treatment with insulin detemir improved glycemic control, weight loss.  // Endocrine Today;Oct2011, Vol. 9 Issue 10, p20 

    The article reports that a randomized trial has found that adding insulin detemir to a treatment regimen of metformin and liraglutide resulted to improved glycemic control and sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

  • Can 15 LB reverse diabetes? Davis, James; R.M.D. // Cortlandt Forum;11/25/95, Vol. 8 Issue 11, p87 

    Answers the question on studies proving that small weight loss can reverse adult-onset diabetes mellitus. Indication of the little effect of a small amount of weight loss.

  • The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes. Scheen, Andr� J. // Current Protein & Peptide Science;Feb2009, Vol. 10 Issue 1, p56 

    Type 2 diabetes is closely related to abdominal obesity and is generally associated with other cardiometabolic risk factors, resulting in a high incidence of cardiovascular complications. Several animal and human observations suggest that the endocannabinoid (EC) system is overactivated in...

  • Diabetes remission after bariatric surgery: is it just the incretins? Laferr&;#x00E8;re, B // International Journal of Obesity;Sep2011 Supplement, Vol. 35, pS22 

    Gastric bypass surgery (GBP) results in important and sustained weight loss and remarkable improvement of Type 2 diabetes. The favorable change in the incretin gut hormones is thought to be responsible, in part, for diabetes remission after GBP, independent of weight loss. However, the relative...

  • Obesity in type 2 diabetes.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS54 

    The article offers information on the management of obesity in patients with type 2 diabetes mellitus. It focuses on diet and exercise, behavioural therapy, and pharmacotherapy and bariatric surgery. It provides up-to-date guidelines on the management of obesity in diabetic patients. It informs...

  • Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. Nisal, Kaustubh; Kela, Ram; Khunti, Kamlesh; Davies, Melanie J. // BMC Medicine;2012, Vol. 10 Issue 1, p1 

    Type 2 diabetes mellitus is widely prevalent and is often coexistent with obesity. Many of the available treatment options have side effects such as weight gain which often affect patient's willingness to continue the treatment. Effective weight loss, lack of significant hypoglycaemia, and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics